Key Details
Price
$0.62Last Dividend
$62.50Annual EPS
-$0.73Annual ROE
-243.62%Beta
0.81Events Calendar
Next earnings date:
Feb 14, 2025Recent quarterly earnings:
Aug 14, 2024Recent annual earnings:
Dec 30, 2020Next ex-dividend date:
N/ARecent ex-dividend date:
Aug 28, 1996Next split:
N/ARecent split:
June 15, 2017Analyst ratings
Recent major analysts updates
12 July '23 EF Hutton
Buy09 Mar '23 EF Hutton
Buy29 Dec '22 EF Hutton
Buy25 Aug '22 EF Hutton
Buy07 Apr '22 EF Hutton
Buy13 Jan '20 HC Wainwright & Co.
Buy13 Jan '20 H.C. Wainwright
Buy20 Feb '13 Taglich Brothers
Speculative Buy13 Feb '13 Chardan Capital
Buy14 Jan '13 Laidlaw & Co.
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Why Is CEL-SCI (CVM) Stock Down 23% Today?
CVM
InvestorPlace18 July 2023
CEL-SCI (NYSEMKT: CVM ) stock is dropping on Tuesday after the biotechnology company announced details of a public share offering. CEL-SCI is offering up 2.5 million shares of its common stock at a price of $2 per share.
FAQ
- What is the primary business of CEL-SCI?
- What is the ticker symbol for CEL-SCI?
- Does CEL-SCI pay dividends?
- What sector is CEL-SCI in?
- What industry is CEL-SCI in?
- What country is CEL-SCI based in?
- When did CEL-SCI go public?
- Is CEL-SCI in the S&P 500?
- Is CEL-SCI in the NASDAQ 100?
- Is CEL-SCI in the Dow Jones?
- When was CEL-SCI's last earnings report?
- When does CEL-SCI report earnings?
- Should I buy CEL-SCI stock now?
What is the primary business of CEL-SCI?
CVM (CEL-SCI) is a biotechnology company focused on developing innovative therapies for cancer and infectious diseases. Their main product, Multikine, aims to enhance the immune response in cancer patients. The company is dedicated to improving treatment options and patient outcomes through advanced research and clinical trials.
What is the ticker symbol for CEL-SCI?
The ticker symbol for CEL-SCI is NYSE American:CVM
Does CEL-SCI pay dividends?
No, CEL-SCI does not pay dividends
What sector is CEL-SCI in?
CEL-SCI is in the Healthcare sector
What industry is CEL-SCI in?
CEL-SCI is in the Biotechnology industry
What country is CEL-SCI based in?
CEL-SCI is headquartered in United States
When did CEL-SCI go public?
CEL-SCI's initial public offering (IPO) was on 08 December 1983
Is CEL-SCI in the S&P 500?
No, CEL-SCI is not included in the S&P 500 index
Is CEL-SCI in the NASDAQ 100?
No, CEL-SCI is not included in the NASDAQ 100 index
Is CEL-SCI in the Dow Jones?
No, CEL-SCI is not included in the Dow Jones index
When was CEL-SCI's last earnings report?
CEL-SCI's most recent earnings report was on 14 August 2024
When does CEL-SCI report earnings?
The next expected earnings date for CEL-SCI is 14 February 2025
Should I buy CEL-SCI stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions